Radiation Therapy Oncology Group

This study tested whether adding a precise, high-dose radiation treatment (SBRT) to the standard drug sorafenib helps people with advanced liver cancer live longer compared to taking sorafenib alone. About 193 adults with liver cancer that could not be surgically removed took par…

This study looked at men with high-risk prostate cancer to see if adding a drug called TAK-700 to standard hormone therapy and radiation could improve outcomes. About 239 men took part. The main goal was to see if the combination reduced the chance of cancer coming back (measured…

This study looked at 236 women with high-risk early-stage cervical cancer who had already had surgery. All received chemotherapy and radiation, and half also got additional chemo afterward. The goal was to see if the extra chemo helped keep the cancer from coming back or improved…

This study looked at 588 men with intermediate-risk prostate cancer to see if adding external beam radiation to brachytherapy (internal radiation seeds) works better than brachytherapy alone. The goal was to see which approach better controls the cancer over time. Results help do…

This large phase III trial studied nearly 1,000 people with HPV-related oropharynx (throat) cancer. It compared radiation therapy combined with the targeted drug cetuximab versus standard chemoradiotherapy (radiation plus cisplatin). The goal was to see which approach works bette…

This study tested whether adding short-term hormone therapy (androgen deprivation) to higher-dose radiation therapy helps men with intermediate-risk prostate cancer live longer. Over 1,500 men participated, and researchers tracked overall survival and signs of cancer returning. T…